Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota
AbstractContext Diabetic kidney disease (DKD) affects nearly 40% of diabetic patients, often leading to end-stage renal disease that requires renal replacement therapies, such as dialysis and transplantation. The gut microbiota, an integral aspect of human evolution, plays a crucial role in this con...
Saved in:
Main Authors: | Xia-Qing Wu (Author), Lei Zhao (Author), Yan-Long Zhao (Author), Xin-Yao He (Author), Liang Zou (Author), Ying-Yong Zhao (Author), Xia Li (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent advances of gut microbiota in chronic kidney disease patients
by: Ying-Yong Zhao
Published: (2022) -
Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis
by: Tingting Luo, et al.
Published: (2024) -
Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease
by: Tian-Yi Cheng, et al.
Published: (2021) -
The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
by: Yinghui Huang, et al.
Published: (2022) -
Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease
by: Bo Zhang, et al.
Published: (2022)